We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.27%
AUM
$600M
AUM Growth
+$17.4M
Cap. Flow
-$111M
Cap. Flow %
-18.53%
Top 10 Hldgs %
46.91%
Holding
88
New
3
Increased
52
Reduced
18
Closed
6

Top Buys

Rank Stock Value
1
U icon
Unity
U
+$1.21M
2
COIN icon
Coinbase
COIN
+$768K
3
BMY icon
Bristol-Myers Squibb
BMY
+$520K
4
VZ icon
Verizon
VZ
+$379K
5
LMT icon
Lockheed Martin
LMT
+$372K

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$100M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$10.5M
3
IDXX icon
Idexx Laboratories
IDXX
+$2.01M
4
ABMD
Abiomed Inc
ABMD
+$1.84M
5
TDOC icon
Teladoc Health
TDOC
+$1.32M

Sector Composition

Rank Sector Weight
1 Healthcare 33.14%
2 Technology 22.3%
3 Financials 10.98%
4 Consumer Discretionary 10.02%
5 Communication Services 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SO icon
26
Southern Company
SO
$107B
$7.55M 1.26%
109,045
+5,083
+5% +$324K
ADP icon
27
Automatic Data Processing
ADP
$108B
$7.49M 1.25%
30,387
+608
+2% +$138K
ITW icon
28
Illinois Tool Works
ITW
$84.9B
$7.28M 1.21%
29,485
+1,045
+4% +$243K
CVX icon
29
Chevron
CVX
$367B
$7.1M 1.18%
59,866
+2,124
+4% +$241K
BBBY
30
DELISTED
Bed Bath & Beyond Inc
BBBY
$6.84M 1.14%
469,206
-51,519
-10% -$900K
DUK icon
31
Duke Energy
DUK
$97.1B
$6.74M 1.12%
63,667
+3,143
+5% +$319K
BMY icon
32
Bristol-Myers Squibb
BMY
$131B
$6.63M 1.11%
106,421
+8,857
+9% +$520K
GIS icon
33
General Mills
GIS
$19.4B
$6.45M 1.08%
95,784
+4,392
+5% +$279K
LMT icon
34
Lockheed Martin
LMT
$134B
$6.3M 1.05%
17,591
+1,076
+7% +$372K
MMM icon
35
3M
MMM
$94.2B
$6.26M 1.04%
41,781
+2,331
+6% +$347K
MRNA icon
36
Moderna
MRNA
$22.9B
$6.2M 1.03%
24,402
+47
+0.2% +$13.7K
VZ icon
37
Verizon
VZ
$194B
$6.18M 1.03%
118,873
+7,271
+7% +$379K
VFC icon
38
VF Corp
VFC
$5.81B
$6.05M 1.01%
82,665
+3,620
+5% +$264K
AMGN icon
39
Amgen
AMGN
$219B
$5.92M 0.99%
26,097
+1,195
+5% +$252K
SBUX icon
40
Starbucks
SBUX
$121B
$5.73M 0.95%
48,965
+605
+1% +$68.2K
BA icon
41
Boeing
BA
$183B
$4.33M 0.72%
21,495
+1,030
+5% +$218K
ZTS icon
42
Zoetis
ZTS
$31.3B
$3.74M 0.62%
15,313
+260
+2% +$57K
BCRX icon
43
BioCryst Pharmaceuticals
BCRX
$2.4B
$3.73M 0.62%
269,580
+2,100
+0.8% +$27.8K
IOVA icon
44
Iovance Biotherapeutics
IOVA
$2.7B
$3.39M 0.56%
177,463
+626
+0.4% +$13.8K
SWAV
45
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$3.21M 0.54%
17,998
+1,508
+9% +$297K
FANG icon
46
Diamondback Energy
FANG
$52.5B
$3.1M 0.52%
28,715
+705
+3% +$76.4K
TDOC icon
47
Teladoc Health
TDOC
$1.3B
$2.2M 0.37%
23,961
-11,055
-32% -$1.32M
SHOP icon
48
Shopify
SHOP
$194B
$1.69M 0.28%
12,280
-180
-1% -$26.3K
IWF icon
49
iShares Russell 1000 Growth ETF
IWF
$128B
$1.67M 0.28%
21,828
+1,324
+6% +$98.2K
IWP icon
50
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$1.48M 0.25%
12,817
+908
+8% +$106K
1
2
3 4

Similar funds

LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
RTM
RH Tailwind Management West Conshohocken, Pennsylvania $781M AUM
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
QCMNJ
Quantum Capital Management (New Jersey) Northfield, New Jersey $781M AUM 4.96% 1-Year Est. Return
TIS
Titan Investment Solutions London $781M AUM
MO
McMillan Office St. Clair Shores, Michigan $782M AUM
NCM
Nellore Capital Management Redwood City, California $783M AUM 2.58% 1-Year Est. Return

Biondo Investment Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Biondo Investment Advisors held 88 positions worth $600M, up 3% from $583M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Biondo Investment Advisors withdrew a net $111M in Q4 2021, closing 6 positions and reducing 18 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

Against the trend, Biondo Investment Advisors opened a new position in Unity worth $1.14M.

  • Biondo Investment Advisors's largest Q4 2021 buy was Unity: 7,945 shares worth $1.14M.
  • Biondo Investment Advisors added most to Bristol-Myers Squibb in Q4 2021, an estimated $520K increase.
  • Biondo Investment Advisors's biggest Q4 2021 reduction was Intuitive Surgical, cutting an estimated $100M.
  • Biondo Investment Advisors fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2021, selling an estimated $10.5M.
  • Biondo Investment Advisors's ten largest holdings make up 47% of its $600M portfolio in Q4 2021.
  • Biondo Investment Advisors opened 3 new positions and closed 6 in Q4 2021.
  • Biondo Investment Advisors's portfolio value rose 3% quarter-over-quarter to $600M.

Based on Biondo Investment Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.